West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 615,500 | 519,400 | 445,900 | 335,300 | 439,100 |
| Receivables | 385,300 | 373,000 | 340,600 | 333,000 | 319,300 |
| Inventories | 321,300 | 294,900 | 274,800 | 251,000 | 235,700 |
| Other current assets | 51,600 | 51,000 | 49,300 | 58,200 | 64,600 |
| TOTAL | $1,373,700 | $1,238,300 | $1,110,600 | $977,500 | $1,058,700 |
| Non-Current Assets | |||||
| PPE Net | 943,200 | 883,400 | 839,800 | 828,300 | 839,300 |
| Investments And Advances | 214,700 | 209,600 | 199,600 | 197,700 | 192,700 |
| Intangibles | 141,600 | 139,900 | 138,800 | 135,000 | 137,600 |
| Other Non-Current Assets | 120,600 | 111,600 | 103,500 | 108,000 | 113,100 |
| TOTAL | $1,420,100 | $1,344,500 | $1,281,700 | $1,269,000 | $1,282,700 |
| Total Assets | $2,793,800 | $2,582,800 | $2,392,300 | $2,246,500 | $2,341,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 213,100 | 180,300 | 162,300 | 157,900 | 156,800 |
| Accrued Expenses | 132,000 | 96,100 | 69,700 | 61,200 | 73,000 |
| Other current liabilities | 145,900 | 128,900 | 101,900 | 99,700 | 93,500 |
| TOTAL | $503,400 | $447,700 | $375,200 | $344,400 | $341,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 252,900 | 253,400 | 253,900 | 254,400 | 255,000 |
| aiOther Non-Current Liabilities | 149,700 | 158,300 | 156,900 | 151,900 | 138,300 |
| TOTAL | $435,900 | $416,200 | $410,800 | $411,900 | $426,600 |
| Total Liabilities | $939,300 | $863,900 | $786,000 | $756,300 | $768,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,103 | 73,927 | 73,841 | 73,602 | 73,837 |
| Common Shares | 18,800 | 18,800 | 18,800 | 18,800 | 18,800 |
| Retained earnings | 1,846,700 | 1,773,400 | 1,703,000 | 1,611,800 | 1,549,400 |
| Other shareholders' equity | -110,300 | -159,500 | -187,600 | -192,000 | -149,700 |
| TOTAL | $1,854,500 | $1,718,900 | $1,606,300 | $1,490,200 | $1,573,200 |
| Total Liabilities And Equity | $2,793,800 | $2,582,800 | $2,392,300 | $2,246,500 | $2,341,400 |